Companies in #Virology

Develops anti-infective therapies for immunocompromised patients, focusing on severe infectious diseases. Founded as a Bayer spin-off, the company's lead antiviral pritelivir won FDA approval in October 2026 following its acquisition by Asahi Kasei.